C07D 333/02
Not condensed with other rings
Official title: not condensed with other rings
C07D333/02 (Not condensed with other rings) appears on 6,922 US grants and 5,393 published applications in this corpus.
Search patents in C07D- Granted patents
- 6,922
- Published applications
- 5,393
- Assignees
- 2,242
- Inventors
- 17,143
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 108 | 0 |
| 1977 | 107 | 0 |
| 1978 | 155 | 0 |
| 1979 | 83 | 0 |
| 1980 | 117 | 0 |
| 1981 | 104 | 0 |
| 1982 | 117 | 0 |
| 1983 | 75 | 0 |
| 1984 | 99 | 0 |
| 1985 | 90 | 0 |
| 1986 | 72 | 0 |
| 1987 | 87 | 0 |
| 1988 | 101 | 0 |
| 1989 | 110 | 0 |
| 1990 | 120 | 0 |
| 1991 | 103 | 0 |
| 1992 | 106 | 0 |
| 1993 | 117 | 0 |
| 1994 | 101 | 0 |
| 1995 | 113 | 0 |
| 1996 | 130 | 0 |
| 1997 | 142 | 0 |
| 1998 | 157 | 0 |
| 1999 | 134 | 0 |
| 2000 | 149 | 0 |
| 2001 | 178 | 29 |
| 2002 | 220 | 190 |
| 2003 | 188 | 336 |
| 2004 | 177 | 344 |
| 2005 | 143 | 283 |
| 2006 | 201 | 298 |
| 2007 | 202 | 294 |
| 2008 | 167 | 274 |
| 2009 | 199 | 337 |
| 2010 | 218 | 323 |
| 2011 | 218 | 256 |
| 2012 | 219 | 249 |
| 2013 | 230 | 216 |
| 2014 | 212 | 246 |
| 2015 | 205 | 218 |
| 2016 | 175 | 193 |
| 2017 | 160 | 163 |
| 2018 | 124 | 150 |
| 2019 | 118 | 122 |
| 2020 | 118 | 154 |
| 2021 | 89 | 122 |
| 2022 | 93 | 133 |
| 2023 | 74 | 147 |
| 2024 | 79 | 127 |
| 2025 | 71 | 106 |
| 2026 | 47 | 83 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- TEAD inhibitors29 Sep 2026US 12,747,207 B2Orion Corporation
- Amyloid targeting agents and methods of using the same22 Sep 2026US 12,741,949 B2Amydis, Inc.
- Compound, and composition for forming hole transporting layer for perovskite solar cells15 Sep 2026US 12,735,395 B2Tokyo Chemical Industry Co., Ltd.
- Compounds for the treatment of bacterial infections and potentiation of antibiotics8 Sep 2026US 12,728,105 B2Georgia State University Research Foundation, Inc.
- Arylsulfonamides as orexin receptor agonists8 Sep 2026US 12,729,178 B2Research Triangle Institute
- Novel carboxamide derivatives8 Oct 2026US 2026/0308149 A1Angelini Pharma S.P.A.
- Pyridine-piperazine-based scaffolds as highly potent and selective neurolysin activators1 Oct 2026US 2026/0294897 A1Board of Regents of the University of Nebraska
- Usp30 inhibitors and uses thereof1 Oct 2026US 2026/0297026 A1Vincere Biosciences, Inc.
- Thiolactones as microcapsule precursors1 Oct 2026US 2026/0297052 A1FMC Corporation
- Hdac1/2 selective inhibitor and use thereof1 Oct 2026US 2026/0297110 A1Wigen Biomedicine Technology (Shanghai) Co., Ltd.
Most cited
By later US patents
- Phenyl heterocycles as cox-2 inhibitors281US 5,474,995 AMerck Frosst Canada, Inc. · 1995
- Phenyl heterocycles as cox-2 inhibitors208US 5,550,142 AMerck Frosst Canada, Inc. · 1996
- Phenyl heterocycles as COX-2 inhibitors204US 5,536,752 AMerck Frosst Canada, Inc. · 1996
- Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2192US 5,521,213 AMerck Frosst Canada, Inc. · 1996
- Herbicide compositions191US 4,021,224 AStauffer Chemical Company · 1977